Table 1.
Characteristics of included studies selected for meta-analysis
| Author. | Year of Publication | Population | Method | Cases (n) | Controls (n) | Overall Sample Size | Count (Genotype) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetic | Nondiabetic (Control) | |||||||||||
| GG | TG | TT | GG | TG | TT | |||||||
| Joshaghani et al. | 2020 | Iranian | PCR-RFLP | 211 | 202 | 413 | 18 | 77 | 116 | 5 | 48 | 149 |
| Sánchez et al. | 2019 | Venezuelan | PCR-RFLP | 46 | 44 | 90 | 1 | 4 | 41 | 2 | 12 | 30 |
| Nam JS | 2018 | Korean | PCR | 249 | 131 | 380 | 119 | 108 | 22 | 61 | 60 | 10 |
| Hussain et al. | 2018 | Iraqi | PCR-RFLP | 400 | 400 | 800 | 33 | 110 | 257 | 8 | 78 | 314 |
| Momin AA | 2017 | Indian | PCR | 150 | 150 | 300 | 2 | 21 | 127 | 0 | 6 | 144 |
| Sheng T | 2016 | Korean Chinese | PCR | 191 | 138 | 329 | 13 | 81 | 97 | 9 | 63 | 66 |
| Saleh R | 2016 | Bangladeshi | PCR-RFLP | 55 | 40 | 95 | 3 | 19 | 33 | 1 | 12 | 27 |
| Farooq,R | 2018 | Indian | PCR-RFLP | 400 | 300 | 700 | 40 | 168 | 192 | 24 | 123 | 153 |
| Vendramini, M.F. | 2010 | Japanese Brazilians | PCR | 200 | 200 | 400 | 12 | 95 | 93 | 15 | 85 | 100 |
| Potapov,V.A. | 2008 | Russian | PCR | 129 | 117 | 246 | 2 | 10 | 117 | 1 | 8 | 108 |
| Lee,Y.Y. | 2005 | Korean | PCR | 493 | 427 | 920 | 39 | 202 | 252 | 45 | 181 | 201 |
| Al Hannan, F.A. | 2016 | Bahraini | PCR-RFLP | 140 | 66 | 206 | 8 | 32 | 100 | 10 | 0 | 56 |
| Ming-Kai Tsa | 2014 | Taiwan’s Chinese Han | PCR | 149 | 139 | 288 | 9 | 69 | 71 | 12 | 57 | 70 |
| Amal et al. | 2014 | Egyptian | PCR-RFLP | 296 | 209 | 505 | 34 | 145 | 117 | 10 | 78 | 121 |
| Saxena et al. | 2012 | North Indian | PCR-RFLP | 221 | 205 | 426 | 23 | 55 | 143 | 11 | 46 | 148 |
| Fatemeh Namvaran | 2012 | Iranian | PCR | 101 | 128 | 229 | 3 | 31 | 67 | 6 | 21 | 101 |